Journal article
Hearing Loss, Retinal Abnormality, and Seizures in People With Facioscapulohumeral Muscular Dystrophy
Muscle & nerve, Vol.72(5), pp.1156-1160
11/2025
DOI: 10.1002/mus.70007
PMCID: PMC12927615
PMID: 40879179
Abstract
Introduction/Aims
Few studies describing comorbidities in individuals with facioscapulohumeral muscular dystrophy (FSHD) are available. We used data from the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) to identify and describe the prevalence of three comorbidities—hearing loss, retinal abnormalities, and seizures—in individuals with FSHD.
Methods
We analyzed retrospective population-based data from 548 individuals diagnosed with FSHD who had at least one health visit during 2008–2019. The primary variables of interest were the presence of one or more of the three comorbidities and the age at diagnosis of the comorbidity. We calculated percentages of each comorbidity by population characteristics.
Results
Among the study cohort, 17.2% (n = 94) had at least one comorbidity, with 1.5% (n = 8) having multiple comorbidities. Hearing loss (13%; n = 71) was the most frequently reported comorbidity, followed by retinal abnormalities (3.6%; n = 20) and seizures (2.0%; n = 11). Median age at diagnosis for hearing loss, retinal abnormalities, and seizures was 46.5 [interquartile range (IQR):11.8–65.3 years], 58.7 (IQR: 41.5–66.5 years), and 16.5 years (IQR: 3.0–34.7 years), respectively.
Discussion
This study demonstrated that a substantial minority of the study cohort had hearing loss, while fewer had retinal abnormalities and seizures. Age at diagnosis varied widely; hearing loss and retinal disease tended to occur in adults, while for seizures, half were ≤ 10 years old. Our results on the prevalence of comorbid conditions among individuals living with FSHD help provide a better understanding of disease burden and support recommendations for ophthalmological and hearing screenings.
Details
- Title: Subtitle
- Hearing Loss, Retinal Abnormality, and Seizures in People With Facioscapulohumeral Muscular Dystrophy
- Creators
- Shannon N. Kilburn - New York State Department of HealthShiny Thomas - New York State Department of HealthAnne L. Havlik - National Center on Birth Defects and Developmental DisabilitiesKatherine D. Mathews - University of IowaNatalie Street - National Center on Birth Defects and Developmental DisabilitiesAida Soim - New York State Department of HealthMuscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
- Resource Type
- Journal article
- Publication Details
- Muscle & nerve, Vol.72(5), pp.1156-1160
- DOI
- 10.1002/mus.70007
- PMID
- 40879179
- PMCID
- PMC12927615
- NLM abbreviation
- Muscle Nerve
- ISSN
- 0148-639X
- eISSN
- 1097-4598
- Publisher
- Wiley
- Grant note
- National Cancer Institute
This work was supported by the Centers for Disease Control and Prevention by Cooperative Agreement numbers DD001243, DD001248, DD1247, DD001252, DD001250, DD001255, DD001253, DD001245, DD001244, DD001249, DD001246, DD001242, DD001254, and DD001251 and National Cancer Institute Grant P30 CA2014.
- Language
- English
- Electronic publication date
- 08/20/2025
- Date published
- 11/2025
- Academic Unit
- Neurology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Neurology (Pediatrics)
- Record Identifier
- 9984949222902771
Metrics
57 Record Views